Home › Glioma › Pennsylvania › Philadelphia
Pag-aaral pangklinika para sa Glioma sa Philadelphia, PA
16 pag-aaral para sa Glioma ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Philadelphia (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
Nagre-recruitPhase 1/2
- Children's Hospital of Philadelphia, Philadelphia
- Saint Christopher's Hospital for Children, Philadelphia
- Alfred I duPont Hospital for Children, Wilmington · 25 mi ang layo
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
Nagre-recruitPhase 2
- Thomas Jefferson University, Sidney Kimmel Comprehensive Cancer Center, Philadelphia
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Nagre-recruitPhase 1/2
- Children's Hospital of Philadelphia-Center for Childhood Cancer Research, Philadelphia
Evaluation of 18F-Fluciclovine Positron Emission Tomography - Magnetic Resonance Imaging (PET-MRI) in LGG
Nagre-recruitMaagang Phase 1
- The Children s Hospital of Philadelphia, Philadelphia
Targeted Pediatric High-Grade Glioma Therapy
Nagre-recruitObservasyonal na pag-aaral
- Children's Hospital of Philadelphia, Philadelphia
Study of Olutasidenib and Temozolomide in HGG
Nagre-recruitPhase 2
- Children's Hospital of Philadelphia, Philadelphia
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
Nagre-recruitPhase 3
- Thomas Jefferson University Hospital, Philadelphia
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
Nagre-recruitPhase 2
- Children's Hospital of Philadelphia, Philadelphia
Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)
Nagre-recruitPhase 1
- Children's Hospital of Philadelphia, Philadelphia
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Nagre-recruitPhase 2
- Thomas Jefferson University, Philadelphia
Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
Nagre-recruitPhase 1/2
- Children's Hospital of Philadelphia, Philadelphia
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
Nagre-recruitMaagang Phase 1Malugod na tinatanggap ang malusog na boluntaryo
- Children's Hospital of Philadelphia, Philadelphia
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
Nagre-recruitPhase 2
- Children's Hospital of Philadelphia, Philadelphia
A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion
Nagre-recruitMaagang Phase 1
- Children's Hospital of Philadelphia, Philadelphia
All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant Glioma
Nagre-recruitPhase 2
- University of Pennsylvania, Philadelphia
18F-Fluciclovine PET-MRI in High-grade Glioma
Nagre-recruitMaagang Phase 1
- Children's Hospital of Philadelphia, Philadelphia
Pag-aaral para sa Glioma sa ibang lungsod
- New York City, NY25 pag-aaral
- Houston, TX23 pag-aaral
- Boston, MA20 pag-aaral
- Washington, DC19 pag-aaral
- Columbus, OH15 pag-aaral
- Miami, FL15 pag-aaral
- San Francisco, CA14 pag-aaral
- Chicago, IL13 pag-aaral
- Durham, NC12 pag-aaral
- Seattle, WA11 pag-aaral
- St. Louis, MO10 pag-aaral
- Aurora, CO10 pag-aaral
Iba pang pag-aaral sa Philadelphia
- Kanser (lahat ng uri)59 pag-aaral
- Kanser sa Suso56 pag-aaral
- Non-Small Cell Lung Cancer51 pag-aaral
- Metastatic Cancer46 pag-aaral
- Kanser sa Prostate44 pag-aaral
- Colorectal Cancer44 pag-aaral
- Kanser sa Ovary44 pag-aaral
- Kanser sa Baga36 pag-aaral
- Acute Myeloid Leukemia34 pag-aaral
- Pagkabigo ng Puso31 pag-aaral
- Kanser ng Endometrium28 pag-aaral
- Depression26 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.